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Vaccine formulations and vaccination programs against whooping cough (pertussis) vary worldwide. Here, we report the
complete genome sequences of two divergent Bordetella pertussis reference strains used in the production of pertussis vac-
cines.
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Bordetella pertussis is the primary causative agent of whoopingcough (pertussis), a respiratory disease most severe in unvac-
cinated infants. The introduction of vaccines against pertussis
dramatically reduced disease incidence worldwide. However,
many countries have recently experienced disease resurgence, in
part due to genetic divergence of circulating strains. The resulting
antigenic mismatch with vaccine references has led many to con-
clude that B. pertussis is evolving under vaccine-driven selection
(1–5). Adaptation of B. pertussis is complicated by the varied ad-
ministration of whole-cell and acellular vaccines between coun-
tries and the diversity of reference strains used for vaccine produc-
tion (6–8). Here, we report the complete genome sequences of
two such strains used in manufacturing pertussis vaccines: B202
(Lederle Laboratories, strain 134) and B203 (Sanofi-Pasteur MSD,
strain 10536) (9).
Whole-genome shotgun sequencing was performed using a
combination of the PacBio RSII (Pacific Biosciences, Menlo Park,
CA), Illumina HiSeq/MiSeq (Illumina, San Diego, CA), and Argus
(OpGen, Gaithersburg, MD) platforms, as described previously
(10). Briefly, genomic DNA libraries were prepared for PacBio
sequencing using the SMRTbell template prep kit 1.0 and poly-
merase binding kit P4, while Illumina libraries were prepared us-
ing the NEBNext Ultra library prep kit (New England BioLabs,
Ipswich, MA). De novo genome assembly of filtered reads was
performed using the Hierarchical Genome Assembly Process
(HGAP version 3; Pacific Biosciences) at 130 and 144 cover-
age for B202 and B203, respectively. The resulting consensus se-
quences were determined with Quiver (version 1), manually
checked for circularity, and then reordered to match the start of
reference strain Tohama I (accession no. CP010964) (10). To en-
sure accuracy, assemblies were confirmed by comparison to
BamHI and KpnI restriction digestion optical maps using the
Argus system (OpGen) with MapSolver (version 2.1.1; OpGen)
and further polished by mapping either Illumina HiSeq PE-100 or
MiSeq PE-300 reads using CLC Genomics Workbench (version
8.5; CLC bio, Boston, MA). Final assemblies were annotated using
the NCBI automated Prokaryotic Genome Annotation Pipeline
(PGAP).
The average GC content of both B202 and B203 was 67.1%,
with genome sizes of 4,128,979 and 4,134,643 bp, respectively.
Genome annotation identified 3,645 protein-coding genes in
B202 and 3,636 protein-coding genes in B203. Both genomes en-
coded three rRNA operons and 51 tRNAs.
The assemblies were distinct from genomes of vaccine refer-
ence strains Tohama I (GlaxoSmithKline, accession no.
CP010964), CS (China, accession no. CP010963), and 137 (Brazil,
accession no. CP010323), which have been sequenced previously
(10, 11). B202 and B203 were not related, and their genomes dif-
fered from that of Tohama I by multiple rearrangements, as well as
186 and 410 single-nucleotide polymorphisms (SNPs), respec-
tively. The genome of B202 was phylogenetically and structurally
similar, but not identical, to other strains with the profile prn1-
ptxP1-ptxA2-ptxB2-fimH1, such as clinical isolate H375 (acces-
sion no. CP010961) (10). B203 appeared to be closely related to
Brazilian vaccine strain 137, sharing allele profile prn7-ptxP2-
ptxA4-ptxB2-fimH1, but differed by 13 SNPs and a single ~74-kb
inversion flanked by rRNA operon copies.
The availability of these genome sequences provides added res-
olution to known diversity among references used in vaccine pro-
duction and will hopefully aid in the research of immune response
to clinical infection in vaccinated patients.
Accession number(s). The complete genome sequences have
been deposited at DDBJ/EMBL/GenBank under the accession
numbers CP016338 and CP012128 for B. pertussis B202 and B203,
respectively. The versions described in this paper are the first ver-
sions.
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